Pharminox appoints scientific advisory board
This article was originally published in Scrip
Executive Summary
Pharminox (UK) has appointed Dr Lee Arnold, Professor Adrian Harris and Dr Robert Jackson as inaugural members of its scientific advisory board. From 2003-07, Dr Arnold was vice-president of US research at OSI Pharmaceuticals, where he oversaw discovery research in cancer chemistry, biology and leads discovery. Professor Harris is the Cancer Research UK (CR-UK) professor of medical oncology at the University of Oxford and directs the CR-UK molecular oncology laboratories at the Weatherall Institute of Molecular Medicine. Dr Jackson retired as chief scientific officer of Cyclacel in 2007.